NEA Management Company, LLC
Q4 2024 13F Holdings
- Locationtimonium, MD
- Num holdings
42
- Value ($000)
$1,771,876
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001512848
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ACLX ARCELLX INC | COMMON STOCK | 03940C100 | $287.22M | 16 % | 3,745,262 | ||
VRNA VERONA PHARMA PLC | SPONSERED ADS | 925050106 | $259.36M | 15 % | 5,584,753 | ||
TEM TEMPUS AI INC | CL A | 88023B103 | $181.83M | 10 % | 5,385,979 | ||
RYTM RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $162.90M | 9 % | 2,909,956 | ||
NEXTNAV | COMMON STOCK | 65345N106 | $127.42M | 7 % | 8,189,156 | ||
COUR COURSERA INC | COM | 22266M104 | $109.38M | 6 % | 12,867,769 | ||
YB4P SAVARA INC | COM | 805111101 | $75.13M | 4 % | 24,471,264 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | $66.61M | 4 % | 3,614,486 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $62.50M | 4 % | 1,587,854 | ||
GLUE MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | $53.38M | 3 % | 7,692,298 |
Rows Per Page
1 - 10 of 4210
- 10
- 50
- 100